Seres Therapeutics
MCRB
MCRB
123 hedge funds and large institutions have $588M invested in Seres Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.45% less ownership
Funds ownership: 4.67% → 4.22% (-0.45%)
21% less capital invested
Capital invested by funds: $743M → $588M (-$155M)
Holders
123
Holding in Top 10
1
Calls
$1.87M
Puts
$1.24M
Top Buyers
| 1 | +$4.66M | |
| 2 | +$3.74M | |
| 3 | +$1.49M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.2M |
| 5 |
Millennium Management
New York
|
+$1.15M |
Top Sellers
| 1 | -$62M | |
| 2 | -$3M | |
| 3 | -$2.9M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.31M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.63M |